Prevalence of myeloma precursor state monoclonal gammopathy of undetermined significance in 12372 individuals 10-49 years old

a population-based study from the National Health and Nutrition Examination Survey

O. Landgren, B. I. Graubard, Shaji K Kumar, R. A. Kyle, J. A. Katzmann, K. Murata, R. Costello, Angela Dispenzieri, N. Caporaso, S. Mailankody, N. Korde, M. Hultcrantz, Terry M Therneau, D. R. Larson, James R Cerhan, S Vincent Rajkumar

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

We studied the prevalence of monoclonal gammopathy of undetermined significance (MGUS) in younger individuals, age 10-49 years, using samples from the National Health and Nutritional Examination Survey (NHANES) III. NHANES prevalence rates were standardized to the 2000 US total population. Among 12 372 individuals (4073 blacks, 4146 Mexican-Americans, 3595 whites, and 558 others), MGUS was identified in 63 persons (0.34%, 95% CI 0.23-0.50). The prevalence of MGUS was significantly higher in blacks (0.88%, 95% CI 0.62-1.26) compared with whites (0.22%, 95% CI 0.11-0.45), P=0.001. The prevalence of MGUS in Mexican-Americans was at an intermediate level (0.41%, 95% CI 0.23-0.73). The disparity in prevalence of MGUS between blacks and whites was most striking in the 40-49 age-group; 3.26% (95% CI 2.04-5.18) versus 0.53% (95% CI 0.20-1.37), P=0.0013. There was a trend to earlier age of onset of MGUS in blacks compared with whites. MGUS was seen in only two persons in the 10-19 age-group (both Mexican-American), and in three persons in the 20-29-year age-group (all of whom were black). In persons less than 50 years of age, MGUS is significantly more prevalent, with up to 10 years earlier age of onset, in blacks compared with whites.

Original languageEnglish (US)
Pages (from-to)e618
JournalBlood Cancer Journal
Volume7
Issue number10
DOIs
StatePublished - Oct 20 2017

Fingerprint

Monoclonal Gammopathy of Undetermined Significance
Nutrition Surveys
Population
Age Groups
Age of Onset
Health

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this

Prevalence of myeloma precursor state monoclonal gammopathy of undetermined significance in 12372 individuals 10-49 years old : a population-based study from the National Health and Nutrition Examination Survey. / Landgren, O.; Graubard, B. I.; Kumar, Shaji K; Kyle, R. A.; Katzmann, J. A.; Murata, K.; Costello, R.; Dispenzieri, Angela; Caporaso, N.; Mailankody, S.; Korde, N.; Hultcrantz, M.; Therneau, Terry M; Larson, D. R.; Cerhan, James R; Rajkumar, S Vincent.

In: Blood Cancer Journal, Vol. 7, No. 10, 20.10.2017, p. e618.

Research output: Contribution to journalArticle

@article{70a8d91aad994858afb77d68579666f4,
title = "Prevalence of myeloma precursor state monoclonal gammopathy of undetermined significance in 12372 individuals 10-49 years old: a population-based study from the National Health and Nutrition Examination Survey",
abstract = "We studied the prevalence of monoclonal gammopathy of undetermined significance (MGUS) in younger individuals, age 10-49 years, using samples from the National Health and Nutritional Examination Survey (NHANES) III. NHANES prevalence rates were standardized to the 2000 US total population. Among 12 372 individuals (4073 blacks, 4146 Mexican-Americans, 3595 whites, and 558 others), MGUS was identified in 63 persons (0.34{\%}, 95{\%} CI 0.23-0.50). The prevalence of MGUS was significantly higher in blacks (0.88{\%}, 95{\%} CI 0.62-1.26) compared with whites (0.22{\%}, 95{\%} CI 0.11-0.45), P=0.001. The prevalence of MGUS in Mexican-Americans was at an intermediate level (0.41{\%}, 95{\%} CI 0.23-0.73). The disparity in prevalence of MGUS between blacks and whites was most striking in the 40-49 age-group; 3.26{\%} (95{\%} CI 2.04-5.18) versus 0.53{\%} (95{\%} CI 0.20-1.37), P=0.0013. There was a trend to earlier age of onset of MGUS in blacks compared with whites. MGUS was seen in only two persons in the 10-19 age-group (both Mexican-American), and in three persons in the 20-29-year age-group (all of whom were black). In persons less than 50 years of age, MGUS is significantly more prevalent, with up to 10 years earlier age of onset, in blacks compared with whites.",
author = "O. Landgren and Graubard, {B. I.} and Kumar, {Shaji K} and Kyle, {R. A.} and Katzmann, {J. A.} and K. Murata and R. Costello and Angela Dispenzieri and N. Caporaso and S. Mailankody and N. Korde and M. Hultcrantz and Therneau, {Terry M} and Larson, {D. R.} and Cerhan, {James R} and Rajkumar, {S Vincent}",
year = "2017",
month = "10",
day = "20",
doi = "10.1038/bcj.2017.97",
language = "English (US)",
volume = "7",
pages = "e618",
journal = "Blood Cancer Journal",
issn = "2044-5385",
publisher = "Nature Publishing Group",
number = "10",

}

TY - JOUR

T1 - Prevalence of myeloma precursor state monoclonal gammopathy of undetermined significance in 12372 individuals 10-49 years old

T2 - a population-based study from the National Health and Nutrition Examination Survey

AU - Landgren, O.

AU - Graubard, B. I.

AU - Kumar, Shaji K

AU - Kyle, R. A.

AU - Katzmann, J. A.

AU - Murata, K.

AU - Costello, R.

AU - Dispenzieri, Angela

AU - Caporaso, N.

AU - Mailankody, S.

AU - Korde, N.

AU - Hultcrantz, M.

AU - Therneau, Terry M

AU - Larson, D. R.

AU - Cerhan, James R

AU - Rajkumar, S Vincent

PY - 2017/10/20

Y1 - 2017/10/20

N2 - We studied the prevalence of monoclonal gammopathy of undetermined significance (MGUS) in younger individuals, age 10-49 years, using samples from the National Health and Nutritional Examination Survey (NHANES) III. NHANES prevalence rates were standardized to the 2000 US total population. Among 12 372 individuals (4073 blacks, 4146 Mexican-Americans, 3595 whites, and 558 others), MGUS was identified in 63 persons (0.34%, 95% CI 0.23-0.50). The prevalence of MGUS was significantly higher in blacks (0.88%, 95% CI 0.62-1.26) compared with whites (0.22%, 95% CI 0.11-0.45), P=0.001. The prevalence of MGUS in Mexican-Americans was at an intermediate level (0.41%, 95% CI 0.23-0.73). The disparity in prevalence of MGUS between blacks and whites was most striking in the 40-49 age-group; 3.26% (95% CI 2.04-5.18) versus 0.53% (95% CI 0.20-1.37), P=0.0013. There was a trend to earlier age of onset of MGUS in blacks compared with whites. MGUS was seen in only two persons in the 10-19 age-group (both Mexican-American), and in three persons in the 20-29-year age-group (all of whom were black). In persons less than 50 years of age, MGUS is significantly more prevalent, with up to 10 years earlier age of onset, in blacks compared with whites.

AB - We studied the prevalence of monoclonal gammopathy of undetermined significance (MGUS) in younger individuals, age 10-49 years, using samples from the National Health and Nutritional Examination Survey (NHANES) III. NHANES prevalence rates were standardized to the 2000 US total population. Among 12 372 individuals (4073 blacks, 4146 Mexican-Americans, 3595 whites, and 558 others), MGUS was identified in 63 persons (0.34%, 95% CI 0.23-0.50). The prevalence of MGUS was significantly higher in blacks (0.88%, 95% CI 0.62-1.26) compared with whites (0.22%, 95% CI 0.11-0.45), P=0.001. The prevalence of MGUS in Mexican-Americans was at an intermediate level (0.41%, 95% CI 0.23-0.73). The disparity in prevalence of MGUS between blacks and whites was most striking in the 40-49 age-group; 3.26% (95% CI 2.04-5.18) versus 0.53% (95% CI 0.20-1.37), P=0.0013. There was a trend to earlier age of onset of MGUS in blacks compared with whites. MGUS was seen in only two persons in the 10-19 age-group (both Mexican-American), and in three persons in the 20-29-year age-group (all of whom were black). In persons less than 50 years of age, MGUS is significantly more prevalent, with up to 10 years earlier age of onset, in blacks compared with whites.

UR - http://www.scopus.com/inward/record.url?scp=85040467300&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85040467300&partnerID=8YFLogxK

U2 - 10.1038/bcj.2017.97

DO - 10.1038/bcj.2017.97

M3 - Article

VL - 7

SP - e618

JO - Blood Cancer Journal

JF - Blood Cancer Journal

SN - 2044-5385

IS - 10

ER -